The growing prevalence of dry eye syndrome, affecting over 210 million people worldwide, and an aging population requiring recurrent care are fueling demand for innovative device-assisted therapies.
This collaboration enhances QT Imaging's Cloud SaaS Platform by integrating Olea Medical's advanced visualization, quantitative analytics and AI-ready imaging technologies to support clinical ...
IRVINE, CA / ACCESS Newswire / January 15, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the ...
At MD&M West 2026, Carl Douglass cuts through the hype to show how additive manufacturing truly accelerates Class II and III ...
In 2025, the U.S. Food and Drug Administration (FDA or the Agency) issued a surprising number of enforcement letters to ...
QT Imaging Holdings, Inc. ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce ...
PRNewswire/ -- (Middletown, Delaware) a leading provider of high-value, system-critical elastomer components, announced a ...
PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...
Danaher anticipates a strong 2026 due to its diagnostic portfolio being in highly attractive areas such as molecular testing, ...
Inquis Medical, Inc., a privately held medical device company focused on mechanical thrombectomy for venous thromboembolic ...
At the ongoing J.P. Morgan Healthcare Conference, Inspire Medical Systems boasted a five-year revenue set to grow at a CAGR ...
Barchart on MSN
Earnings Kickoff, CPI and Other Can't Miss Items This Week
Markets enter a massive week marking the unofficial start of Q4 earnings season with major financial institutions including JPMorgan (JPM), Bank of America (BAC), and Goldman Sachs (GS) reporting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results